Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Longitudinal assessment of immuno-metabolic parameters in multiple sclerosis patients during treatment with glatiramer acetate.
Central Nervous System Herpes Simplex and Varicella-Zoster Virus Infections in Natalizumab-Treated Patients.
Natalizumab affects the T-cell receptor repertoire in patients with multiple sclerosis.
Glatiramer acetate treatment effects on gene expression in monocytes of multiple sclerosis patients.
Galectin-1 for neuroprotection?
Laquinimod prevents inflammation-induced synaptic alterations occurring in experimental autoimmune encephalomyelitis.
Leber's hereditary optic neuropathy associated with multiple sclerosis: Harding's syndrome.
The epidemiology of multiple sclerosis in Latin America and the Caribbean: a systematic review.
Editorial for JNV issue on PML.
Assessment of sphingosine-1-phosphate receptor expression and associated intracellular signaling cascades in primary cells of the human central nervous system.
Altered microRNA expression in B lymphocytes in multiple sclerosis: Towards a better understanding of treatment effects.
Progress in multiple sclerosis research in the last year.
Intensive immunosuppression with cyclophosphamide in multiple sclerosis. Follow up of 110 patients for 2-6 years.
[A comparison analysis of the use of intravenous β-interferon-1a 30 mcg and subcutaneous β-interferon-1a 44 mcg in routine clinical practice of treatment in patients with multiple sclerosis].
Safety, Tolerability and Efficacy of Monthly Long-acting IM Injection of 80 mg GA Depot in Subjects With RRMS
Genzyme’s Lemtrada™ approved in Australia for treatment of multiple sclerosis
Arzerra receives approval in Japan
Calcitriol Modulates the CD46 Pathway in T Cells.
Disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with daclizumab high-yield process in the SELECT study.
22nd Meeting of European Neurological Society
Keystone Symposium on Growing to Extremes: Cell Biology and Pathology of Axons
Development of the Brief Inventory of Perceived Stress.
Multiple sclerosis rebound following herpes zoster infection and suspension of fingolimod.
Recommendations for the clinical use of motor evoked potentials in multiple sclerosis.
Teva Presents New Data Which Demonstrate Reduction of Injection-Related Adverse Events with the Less Frequent Dosing of Three-times-a-week COPAXONE® (glatiramer acetate injection) 40 mg Compared to Daily COPAXONE® 20 mg

Pages